- Home
- SXTC vs GDL Comparison
SXTC vs GDL Comparison
Compare SXTC & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SXTC | GDL |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.9M | 90.1M |
| IPO Year | 2017 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SXTC | GDL |
|---|---|---|
| Price | $2.92 | $8.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 13.6M | 15.2K |
| Earning Date | 08-19-2019 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.02% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $8.01 |
| 52 Week High | $9.59 | $8.67 |
Technical Indicators
Market Signals| Indicator | SXTC | GDL |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 42.39 |
| Support Level | $1.71 | $8.24 |
| Resistance Level | $4.23 | $8.43 |
| Average True Range (ATR) | 0.38 | 0.06 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 69.93 | 18.75 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.